“In recent months we have devoted key resources to our pivotal US paediatric clinical study to ensure that it commenced during the onset of winter and we are very pleased to announce that our first patients have been enrolled on schedule,” said Tony Keating, CEO and Managing Director of ResApp Health.
Ann: ResApp Initiates SMARTCOUGH-C Study in the US, page-12
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)